Wheat
Summary
In 2001 Monsanto was
granted an Australian patent directed to transformation of wheat with
Agrobacterium. Related applications are still pending in Europe and
Canada.
The granted claims of the Australian patent are narrower in their scope than the claims as filed in the European and Canadian applications. In the Australian patent the wheat tissues to be transformed are restricted to certain types of tissues while the applications disclose the transformation of wheat cells derived from any tissue.
Both the Australian patent and the applications disclose the insertion into the cells of genes that confer resistance to selective agents such as gentamycin, kanamycin, and hygromycin. Production of fertile and transgenic wheat plants is also disclosed.
Note that the claim language may be modified during the prosecution process and when granted might not encompass the same scope as the filed claims.
The information contained in this page was believed to be correct at the time it was collated. New patents and patent applications, altered status of patents, and case law may have resulted in changes in the landscape. CAMBIA makes no warranty that it is correct or up to date at this time and accepts no liability for any use that might be made of it. Corrections or updates to the information are welcome. Please send an email to info@bios.net.
There are no comments.